ECO Animal Health Group (EAH) Stock Overview
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
EAH passed our risk checks.
EAH Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more
ECO Animal Health Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£1.11 |
| 52 Week High | UK£1.17 |
| 52 Week Low | UK£0.50 |
| Beta | -0.020 |
| 1 Month Change | 5.74% |
| 3 Month Change | 36.42% |
| 1 Year Change | 75.40% |
| 3 Year Change | 12.76% |
| 5 Year Change | -66.52% |
| Change since IPO | 231.50% |
Recent News & Updates
Earnings Not Telling The Story For ECO Animal Health Group plc (LON:EAH) After Shares Rise 25%
Dec 04
Recent updates
Earnings Not Telling The Story For ECO Animal Health Group plc (LON:EAH) After Shares Rise 25%
Dec 04There's Reason For Concern Over ECO Animal Health Group plc's (LON:EAH) Massive 34% Price Jump
Sep 26ECO Animal Health Group plc (LON:EAH) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Jul 29ECO Animal Health Group's (LON:EAH) Profits May Not Reveal Underlying Issues
Jul 21A Piece Of The Puzzle Missing From ECO Animal Health Group plc's (LON:EAH) Share Price
Apr 25The Price Is Right For ECO Animal Health Group plc (LON:EAH) Even After Diving 31%
Oct 02ECO Animal Health Group plc (LON:EAH) Soars 28% But It's A Story Of Risk Vs Reward
Apr 27ECO Animal Health Group plc (LON:EAH) Shares Could Be 46% Below Their Intrinsic Value Estimate
Apr 10Is There An Opportunity With ECO Animal Health Group plc's (LON:EAH) 38% Undervaluation?
Sep 16Are Investors Undervaluing ECO Animal Health Group plc (LON:EAH) By 44%?
Apr 18An Intrinsic Calculation For ECO Animal Health Group plc (LON:EAH) Suggests It's 38% Undervalued
Dec 22Calculating The Fair Value Of ECO Animal Health Group plc (LON:EAH)
Mar 17ECO Animal Health Group's (LON:EAH) Solid Earnings Have Been Accounted For Conservatively
Dec 02ECO Animal Health Group plc (LON:EAH) Shares Could Be 48% Below Their Intrinsic Value Estimate
Nov 16Are Investors Undervaluing ECO Animal Health Group plc (LON:EAH) By 39%?
Apr 30Analysts Are Betting On ECO Animal Health Group plc (LON:EAH) With A Big Upgrade This Week
Mar 09Investors Who Bought ECO Animal Health Group (LON:EAH) Shares A Year Ago Are Now Up 58%
Mar 06Is ECO Animal Health Group (LON:EAH) Using Too Much Debt?
Feb 08
An Intrinsic Calculation For ECO Animal Health Group plc (LON:EAH) Suggests It's 49% Undervalued
Dec 18Shareholder Returns
| EAH | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -1.8% | 7.4% | 0.7% |
| 1Y | 75.4% | 22.0% | 18.5% |
Return vs Industry: EAH exceeded the UK Pharmaceuticals industry which returned 23.9% over the past year.
Return vs Market: EAH exceeded the UK Market which returned 21.2% over the past year.
Price Volatility
| EAH volatility | |
|---|---|
| EAH Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: EAH has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: EAH's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 200 | David Hallas | ecoanimalhealth.com |
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
ECO Animal Health Group plc Fundamentals Summary
| EAH fundamental statistics | |
|---|---|
| Market cap | UK£75.21m |
| Earnings (TTM) | UK£3.02m |
| Revenue (TTM) | UK£85.81m |
Is EAH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EAH income statement (TTM) | |
|---|---|
| Revenue | UK£85.81m |
| Cost of Revenue | UK£43.71m |
| Gross Profit | UK£42.10m |
| Other Expenses | UK£39.08m |
| Earnings | UK£3.02m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.045 |
| Gross Margin | 49.06% |
| Net Profit Margin | 3.52% |
| Debt/Equity Ratio | 0% |
How did EAH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/06 19:21 |
| End of Day Share Price | 2026/02/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ECO Animal Health Group plc is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Michael Jeremy | Equity Development Limited |
| Andrew Whitney | Investec Bank plc (UK) |
| Jens Lindqvist | Investec Bank plc (UK) |